1947 related articles for article (PubMed ID: 8516616)
1. Possibilities of immunotherapy and gene therapy for malignant melanoma.
Crowley NJ; Seigler HF
Semin Surg Oncol; 1993; 9(3):273-8. PubMed ID: 8516616
[TBL] [Abstract][Full Text] [Related]
2. [A malignus melanoma immunterápiájának lehetoségei].
Ladányi A
Magy Onkol; 2003; 47(1):113-7. PubMed ID: 12704464
[TBL] [Abstract][Full Text] [Related]
3. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R
Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for melanoma.
Komenaka I; Hoerig H; Kaufman HL
Clin Dermatol; 2004; 22(3):251-65. PubMed ID: 15262312
[TBL] [Abstract][Full Text] [Related]
5. [Possibilities of immunotherapy in malignant melanoma].
Lewis MG
Hautarzt; 1978 Dec; 29(12):619-24. PubMed ID: 363650
[TBL] [Abstract][Full Text] [Related]
6. Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration.
Andersen MH; Gehl J; Reker S; Pedersen LØ; Becker JC; Geertsen P; thor Straten P
Semin Cancer Biol; 2003 Dec; 13(6):449-59. PubMed ID: 15001164
[TBL] [Abstract][Full Text] [Related]
7. [Immunotherapeutic possibilities for treatment of malignant melanomas].
Kokoschka EM
Hautarzt; 1979 Dec; 30(12):656-61. PubMed ID: 317654
[TBL] [Abstract][Full Text] [Related]
8. Biologic therapy of melanoma with cytokines and lymphocytes.
Bear HD; Hamad GG; Kostuchenko PJ
Semin Surg Oncol; 1996; 12(6):436-45. PubMed ID: 8914208
[TBL] [Abstract][Full Text] [Related]
9. [Tumor rejection antigen and cancer immunotherapy].
Matsutake T; Nakayama E
Gan To Kagaku Ryoho; 1995 Nov; 22(13):1871-7. PubMed ID: 7487115
[TBL] [Abstract][Full Text] [Related]
10. Melanoma-associated tumor antigens and their clinical relevance to immunotherapy.
Gattoni-Celli S; Cole DJ
Semin Oncol; 1996 Dec; 23(6):754-8. PubMed ID: 8970598
[TBL] [Abstract][Full Text] [Related]
11. [Development in the immunotherapy of malignant melanoma].
Tritsch H
Hautarzt; 1976 Jan; 27(1):1-7. PubMed ID: 767300
[TBL] [Abstract][Full Text] [Related]
12. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
Liu Y; Saxena A; Zheng C; Carlsen S; Xiang J
J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
[TBL] [Abstract][Full Text] [Related]
13. Current concepts of tumor-infiltrating lymphocytes in human malignancies.
Chiou SH; Sheu BC; Chang WC; Huang SC; Hong-Nerng H
J Reprod Immunol; 2005 Oct; 67(1-2):35-50. PubMed ID: 16111767
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapeutic approaches for the treatment of malignant melanoma.
Curiel-Lewandrowski C; Atkins MB
Curr Opin Investig Drugs; 2001 Nov; 2(11):1553-63. PubMed ID: 11763157
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of melanoma.
Rietschel P; Chapman PB
Hematol Oncol Clin North Am; 2006 Jun; 20(3):751-66. PubMed ID: 16762733
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
17. [New therapeutic approachs in melanoma].
Mortier L; Marchetti P; Gordower L; Charbonnier-Hatzfeld AS; Toungouz M; Velu T
Rev Med Brux; 2004 Jun; 25(3):153-9. PubMed ID: 15291447
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
[TBL] [Abstract][Full Text] [Related]
19. Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis.
Leslie MC; Zhao YJ; Lachman LB; Hwu P; Wu GJ; Bar-Eli M
Gene Ther; 2007 Feb; 14(4):316-23. PubMed ID: 17024104
[TBL] [Abstract][Full Text] [Related]
20. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
